10-K Filing

ACCELERATE DIAGNOSTICS, INC CIK: 727207 FY 2013

Filing Information

Form Type	10-K
Accession Number	`0001000096-14-000025`
Period End Date	20131231
Filing Date	20140307
Fiscal Year	2013
Fiscal Period	FY
XBRL Instance	axdx-20131231.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 63 Income Statement 115 Cash Flow Statement 132 Stockholders Equity 58

Balance Sheet 63 line items

Line Item	Tag	Value	Unit	Period
Common Stock, par value	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Common Stock, par value	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Common Stock, shares authorized	`CommonStockSharesAuthorized`	55.00M	shares	Point-in-time
Common Stock, shares authorized	`CommonStockSharesAuthorized`	45.00M	shares	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$14.26M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$30.03M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$283.27K	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$775.86K	USD	Point-in-time
Common Stock, shares issued	`CommonStockSharesIssued`	25.33M	shares	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$587.56K	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$12.07M	USD	Point-in-time
Common Stock, shares issued	`CommonStockSharesIssued`	41.65M	shares	Point-in-time
Investments	`AccruedInvestmentIncomeReceivable`	-	USD	Point-in-time
Investments	`AccruedInvestmentIncomeReceivable`	$11.96M	USD	Point-in-time
Common Stock, shares outstanding	`CommonStockSharesOutstanding`	25.33M	shares	Point-in-time
Common Stock, shares outstanding	`CommonStockSharesOutstanding`	41.65M	shares	Point-in-time
Preferred stock, par value	`PreferredStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Preferred stock, par value	`PreferredStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Trade accounts receivable	`ReceivablesNetCurrent`	$24.40K	USD	Point-in-time
Trade accounts receivable	`ReceivablesNetCurrent`	$763.90K	USD	Point-in-time
Prepaid expenses and other	`PrepaidExpenseAndOtherAssetsCurrent`	$16.38K	USD	Point-in-time
Preferred Stock, shares authorized	`PreferredStockSharesAuthorized`	5.00M	shares	Point-in-time
Prepaid expenses and other	`PrepaidExpenseAndOtherAssetsCurrent`	$130.19K	USD	Point-in-time
Preferred Stock, shares authorized	`PreferredStockSharesAuthorized`	5.00M	shares	Point-in-time
Preferred Stock, shares outstanding	`PreferredStockSharesOutstanding`	-	shares	Point-in-time
Total current assets	`AssetsCurrent`	$42.14M	USD	Point-in-time
Total current assets	`AssetsCurrent`	$12.85M	USD	Point-in-time
Preferred Stock, shares outstanding	`PreferredStockSharesOutstanding`	-	shares	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$147.81K	USD	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$1.05M	USD	Point-in-time
Intellectual property, net	`FiniteLivedIntangibleAssetsNet`	$319.28K	USD	Point-in-time
Intellectual property, net	`FiniteLivedIntangibleAssetsNet`	$240.67K	USD	Point-in-time
Total Assets	`Assets`	$13.32M	USD	Point-in-time
Total Assets	`Assets`	$43.43M	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$299.65K	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$540.43K	USD	Point-in-time
Accrued compensation and other liabilities	`EmployeeRelatedLiabilitiesCurrent`	$514.61K	USD	Point-in-time
Accrued compensation and other liabilities	`EmployeeRelatedLiabilitiesCurrent`	$870.38K	USD	Point-in-time
Deferred revenue and income	`DeferredRevenue`	$81.89K	USD	Point-in-time
Deferred revenue and income	`DeferredRevenue`	$78.03K	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$1.14M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$1.25M	USD	Point-in-time
Long-term deferred income	`LiabilitiesOtherThanLongtermDebtNoncurrent`	-	USD	Point-in-time
Long-term deferred income	`LiabilitiesOtherThanLongtermDebtNoncurrent`	$776.67K	USD	Point-in-time
Total liabilities	`Liabilities`	$1.25M	USD	Point-in-time
Total liabilities	`Liabilities`	$1.91M	USD	Point-in-time
Common stock, $0.001 par value; 55,000,000 common shares authorized (as of December 31, 2013) and 45,000,000 shares (as of December 31, 2012) ; 41,649,521 (as of December 31, 2013) and 25,331,939 (as of December 31, 2012) shares issued and outstanding	`CommonStockNoParValue`	$41.65K	USD	Point-in-time
Common stock, $0.001 par value; 55,000,000 common shares authorized (as of December 31, 2013) and 45,000,000 shares (as of December 31, 2012) ; 41,649,521 (as of December 31, 2013) and 25,331,939 (as of December 31, 2012) shares issued and outstanding	`CommonStockNoParValue`	$25.33K	USD	Point-in-time
Preferred stock, $0.001 par value; 5,000,000 shares authorized and none outstanding (as of December 31, 2013 and December 31, 2012)	`PreferredStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Preferred stock, $0.001 par value; 5,000,000 shares authorized and none outstanding (as of December 31, 2013 and December 31, 2012)	`PreferredStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Contributed capital	`AdditionalPaidInCapitalCommonStock`	$31.24M	USD	Point-in-time
Contributed capital	`AdditionalPaidInCapitalCommonStock`	$75.94M	USD	Point-in-time
Accumulated deficit	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$-34.48M	USD	Point-in-time
Accumulated deficit	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$-19.20M	USD	Point-in-time
Accumulated other comprehensive income	`AccumulatedOtherComprehensiveIncomeLossOtherThanTemporaryImpairmentNotCreditLossNetOfTaxDebtSecurities`	-	USD	Point-in-time
Accumulated other comprehensive income	`AccumulatedOtherComprehensiveIncomeLossOtherThanTemporaryImpairmentNotCreditLossNetOfTaxDebtSecurities`	$21.73K	USD	Point-in-time
Total stockholders' equity	`StockholdersEquity`	$41.52M	USD	Point-in-time
Total stockholders' equity	`StockholdersEquity`	$12.07M	USD	Point-in-time
Total stockholders' equity	`StockholdersEquity`	$14.84M	USD	Point-in-time
Total stockholders' equity	`StockholdersEquity`	$4.91M	USD	Point-in-time
Total stockholders' equity	`StockholdersEquity`	$4.82M	USD	Point-in-time
Total liabilities and stockholders' equity	`LiabilitiesAndStockholdersEquity`	$13.32M	USD	Point-in-time
Total liabilities and stockholders' equity	`LiabilitiesAndStockholdersEquity`	$43.43M	USD	Point-in-time

Income Statement 115 line items

Line Item	Tag	Value	Unit	Period
Technical development fees	`ProfessionalAndContractServicesExpense`	$-140.00K	USD	Annual
Technical development fees	`ProfessionalAndContractServicesExpense`	-	USD	2 Qtrs
Technical development fees	`ProfessionalAndContractServicesExpense`	$-140.00K	USD	2 Qtrs
Technical development fees	`ProfessionalAndContractServicesExpense`	$-842.41K	USD	Annual
Technical development fees	`ProfessionalAndContractServicesExpense`	-	USD	Annual
OptiChem revenue	`LicensesRevenue`	$34.28K	USD	Annual
OptiChem revenue	`LicensesRevenue`	$17.71K	USD	2 Qtrs
OptiChem revenue	`LicensesRevenue`	$45.91K	USD	Annual
OptiChem revenue	`LicensesRevenue`	$48.28K	USD	Annual
OptiChem revenue	`LicensesRevenue`	$62.01K	USD	2 Qtrs
License fees	`CostOfServicesLicensesAndServices`	$-50.00K	USD	Annual
License fees	`CostOfServicesLicensesAndServices`	-	USD	2 Qtrs
License fees	`CostOfServicesLicensesAndServices`	-	USD	2 Qtrs
License fees	`CostOfServicesLicensesAndServices`	-	USD	Annual
License fees	`CostOfServicesLicensesAndServices`	-	USD	Annual
Qualified discovery therapeutic grant	`RevenueFromGrants`	-	USD	2 Qtrs
Qualified discovery therapeutic grant	`RevenueFromGrants`	$244.48K	USD	Annual
Qualified discovery therapeutic grant	`RevenueFromGrants`	-	USD	2 Qtrs
Qualified discovery therapeutic grant	`RevenueFromGrants`	-	USD	Annual
Qualified discovery therapeutic grant	`RevenueFromGrants`	-	USD	Annual
Total revenues	`SalesRevenueNet`	$202.01K	USD	2 Qtrs
Total revenues	`SalesRevenueNet`	$17.71K	USD	2 Qtrs
Total revenues	`SalesRevenueNet`	$1.12M	USD	Annual
Total revenues	`SalesRevenueNet`	$235.91K	USD	Annual
Total revenues	`SalesRevenueNet`	$48.28K	USD	Annual
Research and development	`ResearchAndDevelopmentExpense`	$431.91K	USD	Annual
Research and development	`ResearchAndDevelopmentExpense`	$163.34K	USD	2 Qtrs
Research and development	`ResearchAndDevelopmentExpense`	$1.78M	USD	2 Qtrs
Research and development	`ResearchAndDevelopmentExpense`	$455.00K	USD	Annual
Research and development	`ResearchAndDevelopmentExpense`	$10.67M	USD	Annual
Sales, general and administrative	`GeneralAndAdministrativeExpense`	$819.70K	USD	Annual
Sales, general and administrative	`GeneralAndAdministrativeExpense`	$1.27M	USD	2 Qtrs
Sales, general and administrative	`GeneralAndAdministrativeExpense`	$2.95M	USD	Annual
Sales, general and administrative	`GeneralAndAdministrativeExpense`	$561.70K	USD	2 Qtrs
Sales, general and administrative	`GeneralAndAdministrativeExpense`	$4.31M	USD	Annual
Amortization	`AmortizationOfIntangibleAssets`	$203.46K	USD	Annual
Amortization	`AmortizationOfIntangibleAssets`	$38.02K	USD	2 Qtrs
Amortization	`AmortizationOfIntangibleAssets`	$64.09K	USD	2 Qtrs
Amortization	`AmortizationOfIntangibleAssets`	$253.50K	USD	Annual
Amortization	`AmortizationOfIntangibleAssets`	$76.90K	USD	Annual
Depreciation	`DepreciationDepletionAndAmortization`	$515.00	USD	2 Qtrs
Depreciation	`DepreciationDepletionAndAmortization`	$285.59K	USD	Annual
Depreciation	`DepreciationDepletionAndAmortization`	$2.40K	USD	Annual
Depreciation	`DepreciationDepletionAndAmortization`	$4.64K	USD	2 Qtrs
Depreciation	`DepreciationDepletionAndAmortization`	$2.10K	USD	Annual
Impairment of intangibles	`OtherExpenses`	$11.35K	USD	Annual
Impairment of intangibles	`OtherExpenses`	$2.00M	USD	Annual
Impairment of intangibles	`OtherExpenses`	-	USD	Annual
Impairment of intangibles	`OtherExpenses`	$333.49K	USD	2 Qtrs
Impairment of intangibles	`OtherExpenses`	-	USD	2 Qtrs
Total costs and expenses	`CostsAndExpenses`	$789.64K	USD	2 Qtrs
Total costs and expenses	`CostsAndExpenses`	$1.53M	USD	Annual
Total costs and expenses	`CostsAndExpenses`	$15.36M	USD	Annual
Total costs and expenses	`CostsAndExpenses`	$3.42M	USD	2 Qtrs
Total costs and expenses	`CostsAndExpenses`	$5.59M	USD	Annual
Loss from operations	`OperatingIncomeLoss`	$-409.43K	USD	Annual
Loss from operations	`OperatingIncomeLoss`	$-15.31M	USD	Annual
Loss from operations	`OperatingIncomeLoss`	$-3.40M	USD	2 Qtrs
Loss from operations	`OperatingIncomeLoss`	$-5.35M	USD	Annual
Loss from operations	`OperatingIncomeLoss`	$-587.63K	USD	2 Qtrs
Other expense	`OtherCostAndExpenseOperating`	-	USD	Annual
Other expense	`OtherCostAndExpenseOperating`	-	USD	2 Qtrs
Other expense	`OtherCostAndExpenseOperating`	$4.45K	USD	Annual
Other expense	`OtherCostAndExpenseOperating`	-	USD	Annual
Other expense	`OtherCostAndExpenseOperating`	-	USD	2 Qtrs
Interest and dividend income	`OtherNonoperatingIncome`	$4.05K	USD	2 Qtrs
Interest and dividend income	`OtherNonoperatingIncome`	$16.30K	USD	Annual
Interest and dividend income	`OtherNonoperatingIncome`	$33.49K	USD	Annual
Interest and dividend income	`OtherNonoperatingIncome`	$16.09K	USD	Annual
Interest and dividend income	`OtherNonoperatingIncome`	$1.92K	USD	2 Qtrs
Unrealized holding gain (loss) on investments	`UnrealizedGainLossOnMarketableSecuritiesCostMethodInvestmentsAndOtherInvestments`	$14.57K	USD	Annual
Unrealized holding gain (loss) on investments	`UnrealizedGainLossOnMarketableSecuritiesCostMethodInvestmentsAndOtherInvestments`	-	USD	2 Qtrs
Unrealized holding gain (loss) on investments	`UnrealizedGainLossOnMarketableSecuritiesCostMethodInvestmentsAndOtherInvestments`	-	USD	Annual
Unrealized holding gain (loss) on investments	`UnrealizedGainLossOnMarketableSecuritiesCostMethodInvestmentsAndOtherInvestments`	$23.99K	USD	Annual
Unrealized holding gain (loss) on investments	`UnrealizedGainLossOnMarketableSecuritiesCostMethodInvestmentsAndOtherInvestments`	$-4.37K	USD	2 Qtrs
Unrealized holding gain on asset sale	`UnrealizedGainOnSecurities`	-	USD	2 Qtrs
Unrealized holding gain on asset sale	`UnrealizedGainOnSecurities`	-	USD	Annual
Unrealized holding gain on asset sale	`UnrealizedGainOnSecurities`	$1.00K	USD	Annual
Unrealized holding gain on asset sale	`UnrealizedGainOnSecurities`	$1.00K	USD	2 Qtrs
Unrealized holding gain on asset sale	`UnrealizedGainOnSecurities`	-	USD	Annual
Total other income	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments`	$41.28K	USD	Annual
Total other income	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments`	$1.92K	USD	2 Qtrs
Total other income	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments`	$679.00	USD	2 Qtrs
Total other income	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments`	$30.66K	USD	Annual
Total other income	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments`	$29.04K	USD	Annual
Net loss	`NetIncomeLoss`	$-586.95K	USD	2 Qtrs
Net loss	`NetIncomeLoss`	$-3.40M	USD	2 Qtrs
Net loss	`NetIncomeLoss`	$-15.28M	USD	Annual
Net loss	`NetIncomeLoss`	$-378.76K	USD	Annual
Net loss	`NetIncomeLoss`	$-5.31M	USD	Annual
Basic and diluted net loss per share	`EarningsPerShareBasicAndDiluted`	$-0.43	USD	Annual
Basic and diluted net loss per share	`EarningsPerShareBasicAndDiluted`	$-0.05	USD	2 Qtrs
Basic and diluted net loss per share	`EarningsPerShareBasicAndDiluted`	$-0.04	USD	Annual
Basic and diluted net loss per share	`EarningsPerShareBasicAndDiluted`	$-0.41	USD	Annual
Basic and diluted net loss per share	`EarningsPerShareBasicAndDiluted`	$-0.13	USD	2 Qtrs
Weighted average shares outstanding	`WeightedAverageNumberOfSharesOutstandingBasic`	10.79M	shares	Annual
Weighted average shares outstanding	`WeightedAverageNumberOfSharesOutstandingBasic`	12.43M	shares	Annual
Weighted average shares outstanding	`WeightedAverageNumberOfSharesOutstandingBasic`	37.50M	shares	Annual
Weighted average shares outstanding	`WeightedAverageNumberOfSharesOutstandingBasic`	25.29M	shares	2 Qtrs
Weighted average shares outstanding	`WeightedAverageNumberOfSharesOutstandingBasic`	11.10M	shares	2 Qtrs
Net loss	`NetIncomeLoss`	$-586.95K	USD	2 Qtrs
Net loss	`NetIncomeLoss`	$-3.40M	USD	2 Qtrs
Net loss	`NetIncomeLoss`	$-15.28M	USD	Annual
Net loss	`NetIncomeLoss`	$-378.76K	USD	Annual
Net loss	`NetIncomeLoss`	$-5.31M	USD	Annual
Net unrealized gain/(loss) on available-for-sale investments	`UnrealizedGainLossOnInvestments`	-	USD	Annual
Net unrealized gain/(loss) on available-for-sale investments	`UnrealizedGainLossOnInvestments`	-	USD	2 Qtrs
Net unrealized gain/(loss) on available-for-sale investments	`UnrealizedGainLossOnInvestments`	$21.73K	USD	Annual
Net unrealized gain/(loss) on available-for-sale investments	`UnrealizedGainLossOnInvestments`	-	USD	Annual
Net unrealized gain/(loss) on available-for-sale investments	`UnrealizedGainLossOnInvestments`	-	USD	2 Qtrs
Comprehensive loss	`ComprehensiveIncomeNetOfTax`	$-3.40M	USD	2 Qtrs
Comprehensive loss	`ComprehensiveIncomeNetOfTax`	$-586.95K	USD	2 Qtrs
Comprehensive loss	`ComprehensiveIncomeNetOfTax`	$-378.76K	USD	Annual
Comprehensive loss	`ComprehensiveIncomeNetOfTax`	$-15.26M	USD	Annual
Comprehensive loss	`ComprehensiveIncomeNetOfTax`	$-5.31M	USD	Annual

Cash Flow Statement 132 line items

Line Item	Tag	Value	Unit	Period
Net loss	`NetIncomeLoss`	$-586.95K	USD	2 Qtrs
Net loss	`NetIncomeLoss`	$-3.40M	USD	2 Qtrs
Net loss	`NetIncomeLoss`	$-15.28M	USD	Annual
Net loss	`NetIncomeLoss`	$-378.76K	USD	Annual
Net loss	`NetIncomeLoss`	$-5.31M	USD	Annual
Depreciation	`Depreciation`	$285.59K	USD	Annual
Depreciation	`Depreciation`	$515.00	USD	2 Qtrs
Depreciation	`Depreciation`	$4.64K	USD	2 Qtrs
Depreciation	`Depreciation`	$2.40K	USD	Annual
Depreciation	`Depreciation`	$2.10K	USD	Annual
Amortization of intangible assets	`AmortizationOfIntangibleAssets`	$203.46K	USD	Annual
Amortization of intangible assets	`AmortizationOfIntangibleAssets`	$38.02K	USD	2 Qtrs
Amortization of intangible assets	`AmortizationOfIntangibleAssets`	$64.09K	USD	2 Qtrs
Amortization of intangible assets	`AmortizationOfIntangibleAssets`	$253.50K	USD	Annual
Amortization of intangible assets	`AmortizationOfIntangibleAssets`	$76.90K	USD	Annual
Amortization of investment discount	`InvestmentIncomeAmortizationOfDiscount`	-	USD	2 Qtrs
Amortization of investment discount	`InvestmentIncomeAmortizationOfDiscount`	-	USD	Annual
Amortization of investment discount	`InvestmentIncomeAmortizationOfDiscount`	-	USD	Annual
Amortization of investment discount	`InvestmentIncomeAmortizationOfDiscount`	$75.96K	USD	Annual
Amortization of investment discount	`InvestmentIncomeAmortizationOfDiscount`	-	USD	2 Qtrs
Stock-based compensation	`ShareBasedCompensation`	$3.83M	USD	Annual
Stock-based compensation	`ShareBasedCompensation`	$532.71K	USD	2 Qtrs
Stock-based compensation	`ShareBasedCompensation`	$272.53K	USD	2 Qtrs
Stock-based compensation	`ShareBasedCompensation`	$90.02K	USD	Annual
Stock-based compensation	`ShareBasedCompensation`	$782.00K	USD	Annual
Other expense, impairment loss	`AssetImpairmentCharges`	-	USD	Annual
Other expense, impairment loss	`AssetImpairmentCharges`	-	USD	2 Qtrs
Other expense, impairment loss	`AssetImpairmentCharges`	$11.35K	USD	Annual
Other expense, impairment loss	`AssetImpairmentCharges`	$2.00M	USD	Annual
Other expense, impairment loss	`AssetImpairmentCharges`	$333.49K	USD	2 Qtrs
Unrealized gain on investments	`GainLossOnInvestments`	-	USD	2 Qtrs
Unrealized gain on investments	`GainLossOnInvestments`	$-23.99K	USD	Annual
Unrealized gain on investments	`GainLossOnInvestments`	-	USD	Annual
Unrealized gain on investments	`GainLossOnInvestments`	$-14.57K	USD	Annual
Unrealized gain on investments	`GainLossOnInvestments`	-	USD	2 Qtrs
Realized gain on sale of investments, interest and dividends reinvested	`OtherNoncashExpense`	-	USD	2 Qtrs
Realized gain on sale of investments, interest and dividends reinvested	`OtherNoncashExpense`	-	USD	Annual
Realized gain on sale of investments, interest and dividends reinvested	`OtherNoncashExpense`	$-7.94K	USD	Annual
Realized gain on sale of investments, interest and dividends reinvested	`OtherNoncashExpense`	-	USD	2 Qtrs
Realized gain on sale of investments, interest and dividends reinvested	`OtherNoncashExpense`	$-6.41K	USD	Annual
Accounts receivable	`IncreaseDecreaseInAccountsReceivable`	$590.62K	USD	Annual
Accounts receivable	`IncreaseDecreaseInAccountsReceivable`	$-12.95K	USD	2 Qtrs
Accounts receivable	`IncreaseDecreaseInAccountsReceivable`	$739.50K	USD	Annual
Accounts receivable	`IncreaseDecreaseInAccountsReceivable`	$2.27K	USD	2 Qtrs
Accounts receivable	`IncreaseDecreaseInAccountsReceivable`	$411.48K	USD	Annual
Inventory	`IncreaseDecreaseInInventories`	$20.02K	USD	Annual
Inventory	`IncreaseDecreaseInInventories`	$2.34K	USD	Annual
Inventory	`IncreaseDecreaseInInventories`	-	USD	Annual
Inventory	`IncreaseDecreaseInInventories`	-	USD	2 Qtrs
Inventory	`IncreaseDecreaseInInventories`	$10.26K	USD	2 Qtrs
Prepaid expense and other	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$2.65K	USD	Annual
Prepaid expense and other	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$-1.18K	USD	Annual
Prepaid expense and other	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$-8.21K	USD	2 Qtrs
Prepaid expense and other	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$1.55K	USD	2 Qtrs
Prepaid expense and other	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$-113.81K	USD	Annual
Accounts payable	`IncreaseDecreaseInAccountsPayable`	$39.90K	USD	2 Qtrs
Accounts payable	`IncreaseDecreaseInAccountsPayable`	$28.07K	USD	Annual
Accounts payable	`IncreaseDecreaseInAccountsPayable`	$236.62K	USD	2 Qtrs
Accounts payable	`IncreaseDecreaseInAccountsPayable`	$2.83K	USD	Annual
Accounts payable	`IncreaseDecreaseInAccountsPayable`	$204.15K	USD	Annual
Accrued liabilities	`IncreaseDecreaseInAccruedLiabilities`	$-355.78K	USD	Annual
Accrued liabilities	`IncreaseDecreaseInAccruedLiabilities`	$7.39K	USD	2 Qtrs
Accrued liabilities	`IncreaseDecreaseInAccruedLiabilities`	$1.29K	USD	Annual
Accrued liabilities	`IncreaseDecreaseInAccruedLiabilities`	$127.04K	USD	2 Qtrs
Accrued liabilities	`IncreaseDecreaseInAccruedLiabilities`	$718.76K	USD	Annual
Deferred revenue and income	`IncreaseDecreaseInDeferredRevenue`	$-10.43K	USD	Annual
Deferred revenue and income	`IncreaseDecreaseInDeferredRevenue`	$780.52K	USD	Annual
Deferred revenue and income	`IncreaseDecreaseInDeferredRevenue`	$-7.31K	USD	2 Qtrs
Deferred revenue and income	`IncreaseDecreaseInDeferredRevenue`	$75.55K	USD	Annual
Deferred revenue and income	`IncreaseDecreaseInDeferredRevenue`	$95.48K	USD	2 Qtrs
Deferred compensation	`DeferredCompensationArrangementWithIndividualCompensationExpense`	$-72.57K	USD	2 Qtrs
Deferred compensation	`DeferredCompensationArrangementWithIndividualCompensationExpense`	-	USD	Annual
Deferred compensation	`DeferredCompensationArrangementWithIndividualCompensationExpense`	-	USD	2 Qtrs
Deferred compensation	`DeferredCompensationArrangementWithIndividualCompensationExpense`	$95.98K	USD	Annual
Deferred compensation	`DeferredCompensationArrangementWithIndividualCompensationExpense`	$106.94K	USD	Annual
Net cash (used in)/provided by operating activities	`NetCashProvidedByUsedInOperatingActivities`	$448.48K	USD	Annual
Net cash (used in)/provided by operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-185.56K	USD	2 Qtrs
Net cash (used in)/provided by operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-9.75M	USD	Annual
Net cash (used in)/provided by operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-2.14M	USD	2 Qtrs
Net cash (used in)/provided by operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-815.67K	USD	Annual
Purchases of equipment and capitalized patents	`PaymentsToAcquireProductiveAssets`	$95.50K	USD	Annual
Purchases of equipment and capitalized patents	`PaymentsToAcquireProductiveAssets`	$75.34K	USD	Annual
Purchases of equipment and capitalized patents	`PaymentsToAcquireProductiveAssets`	$1.16M	USD	Annual
Purchases of equipment and capitalized patents	`PaymentsToAcquireProductiveAssets`	$158.35K	USD	2 Qtrs
Purchases of equipment and capitalized patents	`PaymentsToAcquireProductiveAssets`	$19.06K	USD	2 Qtrs
Contribution to deferred compensation trust	`AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationEmployeeStockPurchaseProgramRequisiteServicePeriodRecognition`	$-75.00K	USD	Annual
Contribution to deferred compensation trust	`AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationEmployeeStockPurchaseProgramRequisiteServicePeriodRecognition`	-	USD	2 Qtrs
Contribution to deferred compensation trust	`AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationEmployeeStockPurchaseProgramRequisiteServicePeriodRecognition`	-	USD	Annual
Contribution to deferred compensation trust	`AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationEmployeeStockPurchaseProgramRequisiteServicePeriodRecognition`	$16.32K	USD	2 Qtrs
Contribution to deferred compensation trust	`AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationEmployeeStockPurchaseProgramRequisiteServicePeriodRecognition`	$-150.00K	USD	Annual
Purchase of available-for-sale securities	`PaymentsToAcquireMarketableSecurities`	-	USD	2 Qtrs
Purchase of available-for-sale securities	`PaymentsToAcquireMarketableSecurities`	-	USD	2 Qtrs
Purchase of available-for-sale securities	`PaymentsToAcquireMarketableSecurities`	-	USD	Annual
Purchase of available-for-sale securities	`PaymentsToAcquireMarketableSecurities`	-	USD	Annual
Purchase of available-for-sale securities	`PaymentsToAcquireMarketableSecurities`	$-12.01M	USD	Annual
Net cash used in investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-158.35K	USD	2 Qtrs
Net cash used in investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-150.34K	USD	Annual
Net cash used in investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-13.17M	USD	Annual
Net cash used in investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-2.74K	USD	2 Qtrs
Net cash used in investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-245.50K	USD	Annual
Exercise of warrants and options	`ProceedsFromStockOptionsExercised`	$20.97M	USD	Annual
Exercise of warrants and options	`ProceedsFromStockOptionsExercised`	$128.57K	USD	Annual
Exercise of warrants and options	`ProceedsFromStockOptionsExercised`	$194.44K	USD	Annual
Exercise of warrants and options	`ProceedsFromStockOptionsExercised`	$100.00K	USD	2 Qtrs
Exercise of warrants and options	`ProceedsFromStockOptionsExercised`	-	USD	2 Qtrs
Issuance of common stock and warrants	`IssuanceOfStockAndWarrantsForServicesOrClaims`	$14.42M	USD	Annual
Issuance of common stock and warrants	`IssuanceOfStockAndWarrantsForServicesOrClaims`	-	USD	2 Qtrs
Issuance of common stock and warrants	`IssuanceOfStockAndWarrantsForServicesOrClaims`	-	USD	Annual
Issuance of common stock and warrants	`IssuanceOfStockAndWarrantsForServicesOrClaims`	$19.91M	USD	Annual
Issuance of common stock and warrants	`IssuanceOfStockAndWarrantsForServicesOrClaims`	-	USD	2 Qtrs
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$100.00K	USD	2 Qtrs
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	-	USD	2 Qtrs
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$14.55M	USD	Annual
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$194.44K	USD	Annual
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$40.88M	USD	Annual
Increase (decrease) in cash and cash equivalents	`CashAndCashEquivalentsPeriodIncreaseDecrease`	$-188.30K	USD	2 Qtrs
Increase (decrease) in cash and cash equivalents	`CashAndCashEquivalentsPeriodIncreaseDecrease`	$492.58K	USD	Annual
Increase (decrease) in cash and cash equivalents	`CashAndCashEquivalentsPeriodIncreaseDecrease`	$17.96M	USD	Annual
Increase (decrease) in cash and cash equivalents	`CashAndCashEquivalentsPeriodIncreaseDecrease`	$13.49M	USD	Annual
Increase (decrease) in cash and cash equivalents	`CashAndCashEquivalentsPeriodIncreaseDecrease`	$-2.19M	USD	2 Qtrs
Cash and cash equivalents, beginning of period	`CashAndCashEquivalentsAtCarryingValue`	$14.26M	USD	Point-in-time
Cash and cash equivalents, beginning of period	`CashAndCashEquivalentsAtCarryingValue`	$30.03M	USD	Point-in-time
Cash and cash equivalents, beginning of period	`CashAndCashEquivalentsAtCarryingValue`	$283.27K	USD	Point-in-time
Cash and cash equivalents, beginning of period	`CashAndCashEquivalentsAtCarryingValue`	$775.86K	USD	Point-in-time
Cash and cash equivalents, beginning of period	`CashAndCashEquivalentsAtCarryingValue`	$587.56K	USD	Point-in-time
Cash and cash equivalents, beginning of period	`CashAndCashEquivalentsAtCarryingValue`	$12.07M	USD	Point-in-time
Cash and cash equivalents, end of period	`CashAndCashEquivalentsAtCarryingValue`	$14.26M	USD	Point-in-time
Cash and cash equivalents, end of period	`CashAndCashEquivalentsAtCarryingValue`	$30.03M	USD	Point-in-time
Cash and cash equivalents, end of period	`CashAndCashEquivalentsAtCarryingValue`	$283.27K	USD	Point-in-time
Cash and cash equivalents, end of period	`CashAndCashEquivalentsAtCarryingValue`	$775.86K	USD	Point-in-time
Cash and cash equivalents, end of period	`CashAndCashEquivalentsAtCarryingValue`	$587.56K	USD	Point-in-time
Cash and cash equivalents, end of period	`CashAndCashEquivalentsAtCarryingValue`	$12.07M	USD	Point-in-time

Stockholders Equity 58 line items

Line Item	Tag	Value	Unit	Period
Beginning Balance, Shares	`SharesIssued`	10.76M	shares	Point-in-time
Beginning Balance, Shares	`SharesIssued`	41.65M	shares	Point-in-time
Beginning Balance, Shares	`SharesIssued`	25.23M	shares	Point-in-time
Beginning Balance, Shares	`SharesIssued`	11.10M	shares	Point-in-time
Beginning Balance, Shares	`SharesIssued`	25.33M	shares	Point-in-time
Beginning Balance, Amount	`StockholdersEquity`	$41.52M	USD	Point-in-time
Beginning Balance, Amount	`StockholdersEquity`	$12.07M	USD	Point-in-time
Beginning Balance, Amount	`StockholdersEquity`	$14.84M	USD	Point-in-time
Beginning Balance, Amount	`StockholdersEquity`	$4.91M	USD	Point-in-time
Beginning Balance, Amount	`StockholdersEquity`	$4.82M	USD	Point-in-time
Net Loss	`NetIncomeLoss`	$-586.95K	USD	2 Qtrs
Net Loss	`NetIncomeLoss`	$-3.40M	USD	2 Qtrs
Net Loss	`NetIncomeLoss`	$-15.28M	USD	Annual
Net Loss	`NetIncomeLoss`	$-378.76K	USD	Annual
Net Loss	`NetIncomeLoss`	$-5.31M	USD	Annual
Issuance of Common Stock and Warrants, Shares	`StockIssuedDuringPeriodSharesNewIssues`	-	shares	Annual
Issuance of Common Stock and Warrants, Shares	`StockIssuedDuringPeriodSharesNewIssues`	-	shares	2 Qtrs
Issuance of Common Stock and Warrants, Shares	`StockIssuedDuringPeriodSharesNewIssues`	14.00M	shares	Annual
Issuance of Common Stock and Warrants, Shares	`StockIssuedDuringPeriodSharesNewIssues`	2.49M	shares	Annual
Issuance of Common Stock and Warrants, Amount	`StockIssuedDuringPeriodValueNewIssues`	-	USD	2 Qtrs
Issuance of Common Stock and Warrants, Amount	`StockIssuedDuringPeriodValueNewIssues`	-	USD	Annual
Issuance of Common Stock and Warrants, Amount	`StockIssuedDuringPeriodValueNewIssues`	$19.91M	USD	Annual
Issuance of Common Stock and Warrants, Amount	`StockIssuedDuringPeriodValueNewIssues`	$14.42M	USD	Annual
Exercise of Options and Warrants, Shares	`StockIssuedDuringPeriodSharesAcquisitions`	13.83M	shares	Annual
Exercise of Options and Warrants, Shares	`StockIssuedDuringPeriodSharesAcquisitions`	128,572.00	shares	Annual
Exercise of Options and Warrants, Shares	`StockIssuedDuringPeriodSharesAcquisitions`	100,000.00	shares	2 Qtrs
Exercise of Options and Warrants, Shares	`StockIssuedDuringPeriodSharesAcquisitions`	346,050.00	shares	Annual
Exercise of Options and Warrants, Amount	`StockIssuedDuringPeriodValueAcquisitions`	$128.57K	USD	Annual
Exercise of Options and Warrants, Amount	`StockIssuedDuringPeriodValueAcquisitions`	$194.44K	USD	Annual
Exercise of Options and Warrants, Amount	`StockIssuedDuringPeriodValueAcquisitions`	$20.97M	USD	Annual
Exercise of Options and Warrants, Amount	`StockIssuedDuringPeriodValueAcquisitions`	$100.00K	USD	2 Qtrs
Transfer of Rabbi Trust, Amount	`AdjustmentsToAdditionalPaidInCapitalOther`	-	USD	2 Qtrs
Transfer of Rabbi Trust, Amount	`AdjustmentsToAdditionalPaidInCapitalOther`	-	USD	Annual
Transfer of Rabbi Trust, Amount	`AdjustmentsToAdditionalPaidInCapitalOther`	-	USD	Annual
Transfer of Rabbi Trust, Amount	`AdjustmentsToAdditionalPaidInCapitalOther`	-	USD	Annual
Establish par value stock for DE Corp, Amount	`StockholdersEquityOther`	-	USD	2 Qtrs
Establish par value stock for DE Corp, Amount	`StockholdersEquityOther`	-	USD	Annual
Establish par value stock for DE Corp, Amount	`StockholdersEquityOther`	-	USD	Annual
Establish par value stock for DE Corp, Amount	`StockholdersEquityOther`	-	USD	Annual
Equity Based Compensation	`ShareBasedCompensation`	$3.83M	USD	Annual
Equity Based Compensation	`ShareBasedCompensation`	$532.71K	USD	2 Qtrs
Equity Based Compensation	`ShareBasedCompensation`	$272.53K	USD	2 Qtrs
Equity Based Compensation	`ShareBasedCompensation`	$90.02K	USD	Annual
Equity Based Compensation	`ShareBasedCompensation`	$782.00K	USD	Annual
Unrealized gain on available for sale securities	`AvailableForSaleSecuritiesChangeInNetUnrealizedHoldingGainLoss`	$21.73K	USD	Annual
Unrealized gain on available for sale securities	`AvailableForSaleSecuritiesChangeInNetUnrealizedHoldingGainLoss`	-	USD	2 Qtrs
Unrealized gain on available for sale securities	`AvailableForSaleSecuritiesChangeInNetUnrealizedHoldingGainLoss`	-	USD	Annual
Unrealized gain on available for sale securities	`AvailableForSaleSecuritiesChangeInNetUnrealizedHoldingGainLoss`	-	USD	Annual
Ending Balance, Shares	`SharesIssued`	10.76M	shares	Point-in-time
Ending Balance, Shares	`SharesIssued`	41.65M	shares	Point-in-time
Ending Balance, Shares	`SharesIssued`	25.23M	shares	Point-in-time
Ending Balance, Shares	`SharesIssued`	11.10M	shares	Point-in-time
Ending Balance, Shares	`SharesIssued`	25.33M	shares	Point-in-time
Ending Balance, Amount	`StockholdersEquity`	$41.52M	USD	Point-in-time
Ending Balance, Amount	`StockholdersEquity`	$12.07M	USD	Point-in-time
Ending Balance, Amount	`StockholdersEquity`	$14.84M	USD	Point-in-time
Ending Balance, Amount	`StockholdersEquity`	$4.91M	USD	Point-in-time
Ending Balance, Amount	`StockholdersEquity`	$4.82M	USD	Point-in-time

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.